峡部甲状腺乳头状癌手术方式的研究现状

doi:10.3877/cma.j.issn.1674-0793.2023.03.014

近年来，甲状腺乳头状癌的发病率迅速上升，国内外指南对于腺叶甲状腺乳头状癌的手术方式已有较明确的说明，而峡部甲状腺乳头状癌因位置特殊且侵袭性较强，其手术切除范围在相关指南中尚未明确，仍存在争议。本综述通过检索近5年国内外相关文献，对峡部甲状腺乳头状癌的病理学特征、术前诊断和手术治疗等方面进行总结与分析，以期为临床工作提供参考。

关键词: 甲状腺乳头状癌, 甲状腺峡部扩大切除术, 甲状腺全部切除术, 峡部, 淋巴结转移

In recent years, the incidence of papillary thyroid carcinoma has been rapidly increasing, and various guidelines at home and abroad have clearly stated the surgical approach for tumors located in the lobes of the gland, while the scope of surgical resection of papillary thyroid carcinoma located in the isthmus has not been clearly defined in the relevant guidelines due to its special location and strong invasion, and there is still controversy. This article summarizes and analyzes the pathological features, preoperative diagnosis and surgical treatment of papillary thyroid carcinoma of the isthmus by searching the relevant domestic and international literature in the past 5 years, with the aim of providing reference for clinical work.

Key words: Papillary thyroid carcinoma, Enlarged thyroid isthmus resection, Total thyroidectomy, Isthmus, Lymph node metastasis

[1]	Lyu YS, Pyo JS, Cho WJ, et al. Clinicopathological significance of papillary thyroid carcinoma located in the isthmus: A meta-analysis[J]. World J Surg, 2021, 45(9): 2759-2768.
[2]	Lim ST, Jeon YW, Suh YJ. Correlation between surgical extent and prognosis in node-negative, early-stage papillary thyroid carcinoma originating in the isthmus[J]. World J Surg, 2016, 40(2): 344-349.
[3]	Lee YS, Jeong JJ, Nam KH, et al. Papillary carcinoma located in the thyroid isthmus[J]. World J Surg, 2010, 34(1): 36-39.
[4]	Luo H, Yan F, Lan L, et al. Ultrasonographic features, nodule size, capsular invasion, and lymph node metastasis of solitary papillary carcinoma of thyroid isthmus[J]. Front Oncol, 2020, 10: 558363.
[5]	Feng JW, Qu Z, Qin AC, et al. Significance of multifocality in papillary thyroid carcinoma[J]. Eur J Surg Oncol, 2020, 46(10 Pt A): 1820-1828.
[6]	Bortz MD, Kuchta K, Winchester DJ, et al. Extrathyroidal extension predicts negative clinical outcomes in papillary thyroid cancer[J]. Surgery, 2021, 169(1): 2-6.
[7]	Seok J, Choi JY, Yu HW, et al. Papillary thyroid cancers of the thyroid isthmus: the pattern of nodal metastasis and the significance of extrathyroidal extension[J]. Ann Surg Oncol, 2020, 27(6): 1937-1944.
[8]	Park H, Harries V, McGill MR, et al. Isthmusectomy in selected patients with well-differentiated thyroid carcinoma[J]. Head Neck, 2020, 42(1): 43-49.
[9]	Zhang C, Li BJ, Liu Z, et al. Predicting the factors associated with central lymph node metastasis in clinical node-negative (cN0) papillary thyroid microcarcinoma[J]. Eur Arch Otorhinolaryngol, 2020, 277(4): 1191-1198.
[10]	Feng JW, Qu Z, Ye J, et al. Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma[J]. Surgery, 2021, 170(6): 1670-1679.
[11]	Zhou L, Gao C, Li H, et al. Isthmic papillary thyroid carcinoma presents a unique pattern of central lymph node metastasis[J]. Cancer Manag Res, 2020, 12: 3643-3650.
[12]	Gui Z, Wang Z, Xiang J, et al. Comparison of outcomes following thyroid isthmusectomy, unilateral thyroid lobectomy, and total thyroidectomy in patients with papillary thyroid microcarcinoma of the thyroid isthmus: A retrospective study at a single center[J]. Med Sci Monit, 2020, 26: e927407.
[13]	梁理娟, 蒙万添, 赖华强, 等. 彩色多普勒超声检查在甲状腺恶性肿瘤的诊断价值[J/CD].中华消化病与影像杂志(电子版), 2022, 12(5): 274-277.
[14]	郑祎, 詹维伟. 超声鉴别甲状腺峡部结节良恶性的研究[J/CD]. 中华医学超声杂志(电子版), 2020, 17(11): 1114-1120.
[15]	赵佳航, 张艳, 罗渝昆, 等. 超声与CT检查在诊断甲状腺乳头状癌颈部淋巴结转移中的对比分析[J]. 中国医学科学院学报, 2022, 44(1): 65-71.
[16]	韩志江, 谢乐斯, 魏培英, 等. CT对甲状腺乳头状癌被膜侵犯及颈部淋巴结转移的预测价值[J]. 中华放射学杂志, 2021, 55(7): 723-728.
[17]	Zhang X, Zhang X, Du W, et al. Fine needle biopsy versus core needle biopsy combined with/without thyroglobulin or BRAF ^600E mutation assessment for detecting cervical nodal metastasis of papillary thyroid carcinoma[J]. Front Endocrinol (Lausanne), 2021, 12: 663720.
[18]	Prete A, Borges de Souza P, Censi S, et al. Update on fundamental mechanisms of thyroid cancer[J]. Front Endocrinol (Lausanne), 2020, 11: 102.
[19]	Zheng L, Liu FY, Yu J, et al. Thermal ablation for papillary thyroid microcarcinoma located in the isthmus: A study with 3 years of follow-up[J]. Future Oncol, 2022, 18(4): 471-480.
[20]	Horiguchi K, Yoshida Y, Iwaku K, et al. Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults[J]. Endocr J, 2021, 68(7): 763-780.
[21]	Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133.
[22]	中华人民共和国国家卫生健康委员会. 甲状腺癌诊疗规范(2018年版)[J/CD]. 中华普通外科学文献(电子版), 2019, 13(1): 1-15.
[23]	Nixon IJ, Palmer FL, Whitcher MM, et al. Thyroid isthmusectomy for well-differentiated thyroid cancer[J]. Ann Surg Oncol, 2011, 18(3): 767-770.
[24]	Campennì A, Piantanida R, Giovanella L. Is isthmic enucleo-resection a reliable treatment for isthmic differentiated thyroid carcinoma? A note of caution[J]. J Endocrinol Invest, 2020, 43(12): 1829-1830.
[25]	Huang H, Yan D, Liu W, et al. Isthmectomy is effective and sufficient for selected patients with the isthmus-confined solitary papillary thyroid carcinoma[J]. Asian J Surg, 2022, 45(9): 1678-1681.
[26]	Seo HW, Song CM, Ji YB, et al. Surgical outcomes and efficacy of isthmusectomy in single isthmic papillary thyroid carcinoma: A preliminary retrospective study[J]. J Invest Surg, 2021, 34(10): 1129-1134.
[27]	Goldfarb M, Rodgers SS, Lew JI. Appropriate surgical procedure for dominant thyroid nodules of the isthmus 1 cm or larger[J]. Arch Surg, 2012, 147(9): 881-884.
[28]	Lei J, Zhu J, Li Z, et al. Surgical procedures for papillary thyroid carcinoma located in the thyroid isthmus: An intention-to-treat analysis[J]. Onco Targets Ther, 2016, 9: 5209-5216.
[29]	Shuai Y, Yue K, Duan Y, et al. Surgical extent of central lymph node dissection for papillary thyroid carcinoma located in the isthmus: A propensity scoring matched study[J]. Front Endocrinol (Lausanne), 2021, 12: 620147.
[30]	Zhao J, Zhang Y, Zheng X. Clinicopathological characteristics of papillary thyroid cancer located in the isthmus with Delphian lymph node metastasis[J]. Br J Oral Maxillofac Surg, 2022, 60(5): 635-638.
[31]	Li G, Lei J, Peng Q, et al. Lymph node metastasis characteristics of papillary thyroid carcinoma located in the isthmus: A single-center analysis[J]. Medicine (Baltimore), 2017, 96(24): e7143.
[32]	Zhang LZ, Xu JJ, Ge XY, et al. Pathological analysis and surgical modalities selection of cT1N0M0 solitary papillary thyroid carcinoma in the isthmus[J]. Gland Surg, 2021, 10(8): 2445-2454.
[33]	黄煜庆, 温庆良, 曹君, 等. 峡部甲状腺乳头状癌120例临床病理学特征分析[J]. 肿瘤学杂志, 2018, 24(4): 308-312.
[34]	Zhao WJ, Luo H, Zhou YM, et al. Evaluating the effectiveness of prophylactic central neck dissection with total thyroidectomy for cN0 papillary thyroid carcinoma: An updated meta-analysis[J]. Eur J Surg Oncol, 2017, 43(11):1989-2000.
[35]	王梦一, 袁宏伟, 张宁, 等. 峡部甲状腺乳头状癌的诊治探讨[J]. 中华内分泌外科杂志, 2015, 9(1): 9-12.
[36]	Zhou B, Qin J. High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma(cT1N0)[J]. Eur J Surg Oncol, 2021, 47(4): 882-887.
[37]	Kwon O, Lee S, Bae JS, et al. Thyroid isthmusectomy with prophylactic central compartment neck dissection is a feasible approach for papillary thyroid cancer on the isthmus[J]. Ann Surg Oncol, 2021, 28(11): 6603-6612.
[38]	Du W, Fang Q, Zhang X, et al. Metastasis of cN0 papillary thyroid carcinoma of the isthmus to the lymph node posterior to the right recurrent laryngeal nerve[J]. Front Endocrinol (Lausanne), 2021, 12: 677986.

[1]	蔡林利, 宋宏萍, 巨艳, 党晓智, 韩铭, 肖迎聪. 超声结合临床病理指标模型对T1-2期乳腺癌腋窝淋巴结转移的预测价值[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(02): 143-150.
[2]	肖莉莉, 吴道珠, 陈晓乐, 李秀云, 寇红菊. 胎儿心脏参数对胎儿宫内生长受限的预测价值[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(01): 24-31.
[3]	孙帼, 谢迎东, 徐超丽, 杨斌. 超声联合临床特征的列线图模型预测甲状腺乳头状癌淋巴结转移的价值[J/OL]. 中华医学超声杂志（电子版）, 2023, 20(07): 734-742.
[4]	周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[5]	韩婧, 郝少龙, 康骅. 北京市单中心甲状腺癌患者临床特征的回顾分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 490-493.
[6]	黄一博, 李至彦, 林晨, 陶亮, 王萌, 管文贤. 胃癌根治术中淋巴结示踪剂的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 586-588.
[7]	袁育韬, 邢金琳, 谢克飞, 殷凯. CT征象及BRAF^V600E基因突变与甲状腺乳头状癌中央区淋巴结转移的相关性[J/OL]. 中华普外科手术学杂志(电子版), 2023, 17(06): 611-614.
[8]	陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[9]	张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[10]	苑乐添, 王艺霖, 沈子剑, 闫呈新. 血清GDF15、sB7-H1联合多层螺旋CT灌注成像技术对胃癌患者淋巴结转移的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(01): 62-66.
[11]	王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
[12]	卫星彤, 李昊昌, 赵欣. 甲状腺木乃伊结节于多模态超声下的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 415-419.
[13]	杜倩, 张曼, 李丽, 马晓丽. 细胞蜡块技术在甲状腺细针穿刺病理诊断中的价值研究[J/OL]. 中华临床医师杂志(电子版), 2023, 17(10): 1071-1074.
[14]	牟鳄贤, 李卓璇, 董浩, 于淼, 纪娟, 徐佳, 王浩, 刘世伟. 初始腋窝淋巴结转移乳腺癌新辅助治疗后腋窝病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2023, 17(10): 1027-1032.
[15]	姜超, 夏旭东, 王功夏, 何向宇, 王海彬, 李媛. 磁共振DWI及其ADC对乳腺导管原位癌伴微浸润腋窝淋巴结转移的诊断价值[J/OL]. 中华介入放射学电子杂志, 2024, 12(03): 234-243.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Current status of surgical approaches for papillary thyroid carcinoma of the isthmus

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Current status of surgical approaches for papillary thyroid carcinoma of the isthmus